PRE CLINICAL TRIAL

  • Bioimmunate has successfully completed POC of removing specific MS related White Blood Cells from patients’ blood.

  • Trail main research was to validate a removal of specific MS related White Blood cells with expression, purification & anchoring of target Proteins to a biocompatible surface.

  • During the research the technology has been tested on blood samples collected from MS patients and proof average removal of target cells of very high rate.

  • Pre-clinical safety trials on rats proof of safe procedure (no mortality, weight loss or changes in blood tests parameters)

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, visit About Cookies page.